Bovine and Human Papillomaviruses: A Comparative Review

Veterinary Pathology

Volumn 51, Issue 6, 2014, Pages 1063-1075

  Munday, J S ^a  

^a MASSEY UNIVERSITY   (New Zealand)

Author keywords

bovine papillomaviruses; human papillomaviruses; oncogenic viruses; papillomas; review; squamous cell carcinoma

Indexed keywords

ANIMAL; BOVINE; CATTLE DISEASE; CLASSIFICATION; HUMAN; NEOPLASM; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTION; PATHOGENICITY; PATHOLOGY; PHYSIOLOGY; VIROLOGY;

ANIMALS; CATTLE; CATTLE DISEASES; HUMANS; NEOPLASMS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS;

EID: 84908556777     PISSN: 03009858     EISSN: 15442217     Source Type: Journal    
DOI: 10.1177/0300985814537837     Document Type: Article

References (129)

1. Akgul B,Cooke JC,Storey A. HPV-associated skin disease.J Pathol. 2006;208: 165-175
2. Aldabagh B,Angeles JG,Cardones AR, et al. Cutaneous squamous cell carcinoma and human papillomavirus: is there an association?.Dermatol Surg. 2013;39: 1-23
3. Amtmann E,Muller H,Sauer G. Equine connective tissue tumors contain unintegrated bovine papilloma virus DNA.J Virol. 1980;35: 962-964
4. Anderson RA,Scobie L,O’Neil BW, et al. Viral proteins of bovine papillomavirus type 4 during the development of alimentary canal tumours.Vet J. 1997;154: 69-78
5. Araldi RP,Melo TC,Diniz N, et al. Bovine papillomavirus clastogenic effect analyzed in comet assay.Biomed Res Int. 2013;2013: 630683
6. Ashby AD,Meagher L,Campo MS, et al. E5 transforming proteins of papillomaviruses do not disturb the activity of the vacuolar H(+)-ATPase.J Gen Virol. 2001;82: 2353-2362
7. Ashrafi GH,Tsirimonaki E,Marchetti B, et al. Down-regulation of MHC class I by bovine papillomavirus E5 oncoproteins.Oncogene. 2002;21: 248-259
8. Beniston RG,Morgan IM,O’Brien V, et al. Quercetin, E7 and p53 in papillomavirus oncogenic cell transformation.Carcinogenesis. 2001;22: 1069-1076
9. Bernard HU,Burk RD,Chen Z, et al. Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments.Virology. 2010;401: 70-79
10. Bogaert L,Martens A,Van Poucke M, et al. High prevalence of bovine papillomaviral DNA in the normal skin of equine sarcoid-affected and healthy horses.Vet Microbiol. 2008;129: 58-68
11. Bogaert L,Van Poucke M,De Baere C, et al. Bovine papillomavirus load and mRNA expression, cell proliferation and p53 expression in four clinical types of equine sarcoid.J Gen Virol. 2007;88: 2155-2161
12. Bohl J,Hull B,Vande Pol SB. Cooperative transformation and coexpression of bovine papillomavirus type 1 E5 and E7 proteins.J Virol. 2001;75: 513-521
13. Boiron M,Levy JP,Thomas M, et al. Some properties of bovine papilloma virus.Nature. 1964;201: 423-424
14. Borzacchiello G,Iovane G,Marcante ML, et al. Presence of bovine papillomavirus type 2 DNA and expression of the viral oncoprotein E5 in naturally occurring urinary bladder tumours in cows.J Gen Virol. 2003;84: 2921-2926
15. Borzacchiello G,Resendes AR,Roperto S, et al. Co-expression of bovine papillomavirus E5 and E7 oncoproteins in naturally occurring carcinomas of the urinary bladder in cattle.J Comp Pathol. 2009;141: 84-88
16. Borzacchiello G,Russo V,Della Salda L, et al. Expression of platelet-derived growth factor–beta receptor and bovine papillomavirus E5 and E7 oncoproteins in equine sarcoid.J Comp Pathol. 2008;139: 231-237
17. Borzacchiello G,Russo V,Gentile F, et al. Bovine papillomavirus E5 oncoprotein binds to the activated form of the platelet-derived growth factor beta receptor in naturally occurring bovine urinary bladder tumours.Oncogene. 2006;25: 1251-1260
18. Borzacchiello G,Russo V,Spoleto C, et al. Bovine papillomavirus type-2 DNA and expression of E5 and E7 oncoproteins in vascular tumours of the urinary bladder in cattle.Cancer Lett. 2007;250: 82-91
19. Brandt S,Haralambus R,Schoster A, et al. Peripheral blood mononuclear cells represent a reservoir of bovine papillomavirus DNA in sarcoid-affected equines.J Gen Virol. 2008;89: 1390-1395
20. Brandt S,Schoster A,Tober R, et al. Consistent detection of bovine papillomavirus in lesions, intact skin and peripheral blood mononuclear cells of horses affected by hoof canker.Equine Vet J. 2011;43: 202-209
21. Campo MS. Infection by bovine papillomavirus and prospects for vaccination.Trends Microbiol. 1995;3: 92-97
22. Campo MS,Grindlay GJ,O’Neil BW, et al. Prophylactic and therapeutic vaccination against a mucosal papillomavirus.J Gen Virol. 1993;74: 945-953
23. Campo MS,Jarrett WF,Barron R, et al. Association of bovine papillomavirus type 2 and bracken fern with bladder cancer in cattle.Cancer Res. 1992;52: 6898-6904
24. Campo MS,Jarrett WF,O’Neil W, et al. Latent papillomavirus infection in cattle.Res Vet Sci. 1994;56: 151-157
25. Campo MS,Moar MH,Sartirana ML, et al. The presence of bovine papillomavirus type 4 DNA is not required for the progression to, or the maintenance of, the malignant state in cancers of the alimentary canal in cattle.EMBO J. 1985;4: 1819-1825
26. Campo MS,O’Neil BW,Barron RJ, et al. Experimental reproduction of the papilloma-carcinoma complex of the alimentary canal in cattle.Carcinogenesis. 1994;15: 1597-1601
27. Chambers G,Ellsmore VA,O’Brien PM, et al. Association of bovine papillomavirus with the equine sarcoid.J Gen Virol. 2003;84: 1055-1062
28. Chaturvedi AK,Madeleine MM,Biggar RJ, et al. Risk of human papillomavirus–associated cancers among persons with AIDS.J Natl Cancer Inst. 2009;101: 1120-1130
29. Chen AC,Keleher A,Kedda MA, et al. Human papillomavirus DNA detected in peripheral blood samples from healthy Australian male blood donors.J Med Virol. 2009;81: 1792-1796
30. Cheville NF,Olson C. Epithelial and fibroblastic proliferation in bovine cutaneous papillomatosis.Vet Pathol. 1964;1: 248-257
31. Christen G,Gerber V,Dolf G, et al. Inheritance of equine sarcoid disease in Franches-Montagnes horses.Vet J. 2014;199: 68-71
32. Connolly JA,Morgan IM,Jackson ME, et al. The BPV-4 co-carcinogen quercetin induces cell cycle arrest and up-regulates transcription from the LCR of BPV-4.Oncogene. 1998;16: 2739-2746
33. de Villiers EM. Cross-roads in the classification of papillomaviruses.Virology. 2013;445: 2-10
34. DeMasi J,Huh KW,Nakatani Y, et al. Bovine papillomavirus E7 transformation function correlates with cellular p600 protein binding.Proc Natl Acad Sci U S A. 2005;102: 11486-11491
35. Derkay CS,Wiatrak B. Recurrent respiratory papillomatosis: a review.Laryngoscope. 2008;118: 1236-1247
36. DiMaio D,Mattoon D. Mechanisms of cell transformation by papillomavirus E5 proteins.Oncogene. 2001;20: 7866-7873
37. Doorbar J. Molecular biology of human papillomavirus infection and cervical cancer.Clin Sci. 2006;110: 525-541
38. Doorbar J. The papillomavirus life cycle.J Clin Virol. 2005;32: S7-S15
39. Doorbar J,Quint W,Banks L, et al. The biology and life-cycle of human papillomaviruses.Vaccine. 2012;30: F55-F70
40. Dvoretzky I,Shober R,Chattopadhyay SK, et al. A quantitative in vitro focus assay for bovine papilloma virus.Virology. 1980;103: 369-375
41. Gaukroger JM,Chandrachud LM,O’Neil BW, et al. Vaccination of cattle with bovine papillomavirus type 4 L2 elicits the production of virus-neutralizing antibodies.J Gen Virol. 1996;77: 1577-1583
42. Goldstein DJ,Finbow ME,Andresson T, et al. Bovine papillomavirus E5 oncoprotein binds to the 16 K component of vacuolar H(+)-ATPases.Nature. 1991;352: 347-349
43. Gordon PJ. Surgical removal of a fibropapilloma from the reticulum causing apparent vagal indigestion.Vet Rec. 1997;140: 69-70
44. Grindlay GJ,Campo MS,O’Brien V. Transactivation of the cyclin A promoter by bovine papillomavirus type 4 E5 protein.Virus Res. 2005;108: 29-38
45. Hainisch EK,Brandt S,Shafti-Keramat S, et al. Safety and immunogenicity of BPV-1 L1 virus-like particles in a dose-escalation vaccination trial in horses.Equine Vet J. 2012;44: 107-111
46. Hartl B,Hainisch EK,Shafti-Keramat S, et al. Inoculation of young horses with bovine papillomavirus type 1 virions leads to early infection of PBMCs prior to pseudo-sarcoid formation.J Gen Virol. 2011;92: 2437-2445
47. Hood AFPathology of the Skin. Farmer ERHood AF, ed. East Norwark, CT: Appleton & Lange ; 1990:309-317.
48. Jarrett WF,McNeil PE,Grimshaw WT, et al. High incidence area of cattle cancer with a possible interaction between an environmental carcinogen and a papilloma virus.Nature. 1978;274: 215-217
49. Jarrett WF,Murphy J,O’Neil BW, et al. Virus-induced papillomas of the alimentary tract of cattle.Int J Cancer. 1978;22: 323-328
50. Jarrett WF,O’Neil BW,Gaukroger JM, et al. Studies on vaccination against papillomaviruses: a comparison of purified virus, tumour extract and transformed cells in prophylactic vaccination.Vet Rec. 1990;126: 449-452
51. Jarrett WF,Smith KT,O’Neil BW, et al. Studies on vaccination against papillomaviruses: prophylactic and therapeutic vaccination with recombinant structural proteins.Virology. 1991;184: 33-42
52. Jelinek F,Tachezy R. Cutaneous papillomatosis in cattle.J Comp Pathol. 2005;132: 70-81
53. Jensen R,Lauerman LH,England JJ, et al. Laryngeal diphtheria and papillomatosis in feedlot cattle.Vet Pathol. 1981;18: 143-150
54. Jeon S,Lambert PF. Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis.Proc Natl Acad Sci U S A. 1995;92: 1654-1658
55. Kashima H,Mounts P,Leventhal B, et al. Sites of predilection in recurrent respiratory papillomatosis.Ann Otol Rhinol Laryngol. 1993;102: 580-583
56. Kirnbauer R,Chandrachud LM,O’Neil BW, et al. Virus-like particles of bovine papillomavirus type 4 in prophylactic and therapeutic immunization.Virology. 1996;219: 37-44
57. Klingelhutz AJ,Foster SA,McDougall JK. Telomerase activation by the E6 gene product of human papillomavirus type 16.Nature. 1996;380: 79-82
58. Lacey CJ,Lowndes CM,Shah KV. Burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease.Vaccine. 2006;24: 35-41
59. Lancaster WD. Apparent lack of integration of bovine papillomavirus DNA in virus-induced equine and bovine tumor cells and virus-transformed mouse cells.Virology. 1981;108: 251-255
60. Lindelof B,Sigurgeirsson B,Gabel H, et al. Incidence of skin cancer in 5356 patients following organ transplantation.Br J Dermatol. 2000;143: 513-519
61. Lindholm I,Murphy J,O’Neil BW, et al. Papillomas of the teats and udder of cattle and their causal viruses.Vet Rec. 1984;115: 574-577
62. Lindsey CL,Almeida ME,Vicari CF, et al. Bovine papillomavirus DNA in milk, blood, urine, semen, and spermatozoa of bovine papillomavirus-infected animals.Genet Mol Res. 2009;8: 310-318
63. Lucena RB,Rissi DR,Kommers GD, et al. A retrospective study of 586 tumours in Brazilian cattle.J Comp Pathol. 2011;145: 20-24
64. Lunardi M,de Alcantara BK,Otonel RA, et al. Bovine papillomavirus type 13 DNA in equine sarcoids.J Clin Microbiol. 2013;51: 2167-2171
65. Lyronis ID,Baritaki S,Bizakis I, et al. Evaluation of the prevalence of human papillomavirus and Epstein-Barr virus in esophageal squamous cell carcinomas.Int J Biol Markers. 2005;20: 5-10
66. Maglennon GA,McIntosh P,Doorbar J. Persistence of viral DNA in the epithelial basal layer suggests a model for papillomavirus latency following immune regression.Virology. 2011;414: 153-163
67. Marchetti B,Ashrafi GH,Dornan ES, et al. The E5 protein of BPV-4 interacts with the heavy chain of MHC class I and irreversibly retains the MHC complex in the Golgi apparatus.Oncogene. 2006;25: 2254-2263
68. McLaughlin-Drubin ME,Munger K. The human papillomavirus E7 oncoprotein.Virology. 2009;384: 335-344
69. Meischke HR. In vitro transformation by bovine papilloma virus.J Gen Virol. 1979;43: 473-487
70. Munday JS. Papillomaviruses in felids.Vet J. 2014;199: 340-347
71. Munday JS,Hanlon EM,Howe L, et al. Feline cutaneous viral papilloma associated with human papillomavirus type 9.Vet Pathol. 2007;44: 924-927
72. Munday JS,Kiupel M. Papillomavirus-associated cutaneous neoplasia in mammals.Vet Pathol. 2010;47: 254-264
73. Munday JS,Knight CG. Amplification of feline sarcoid-associated papillomavirus DNA sequences from bovine skin.Vet Dermatol. 2010;21: 341-344
74. Munday JS,Knight CG,Howe L. The same papillomavirus is present in feline sarcoids from North America and New Zealand but not in any non-sarcoid feline samples.J Vet Diagn Invest. 2010;22: 97-100
75. Nakabayashi Y,Chattopadhyay SK,Lowy DR. The transforming function of bovine papillomavirus DNA.Proc Natl Acad Sci U S A. 1983;80: 5832-5836
76. Narechania A,Terai M,Chen Z, et al. Lack of the canonical pRB-binding domain in the E7 ORF of artiodactyl papillomaviruses is associated with the development of fibropapillomas.J Gen Virol. 2004;85: 1243-1250
77. Nasir L,Brandt S. Papillomavirus associated diseases of the horse.Vet Microbiol. 2013;167: 159-167
78. Nasir L,Campo MS. Bovine papillomaviruses: their role in the aetiology of cutaneous tumours of bovids and equids.Vet Dermatol. 2008;19: 243-254
79. Nel PJ,Bertschinger H,Williams J, et al. Descriptive study of an outbreak of equine sarcoid in a population of Cape mountain zebra (Equus zebra zebra) in the Gariep Nature Reserve.J S Afr Vet Assoc. 2006;77: 184-190
80. Nicolaides L,Davy C,Raj K, et al. Stabilization of HPV16 E6 protein by PDZ proteins, and potential implications for genome maintenance.Virology. 2011;414: 137-145
81. O’Brien V,Grindlay GJ,Campo MS. Cell transformation by the E5/E8 protein of bovine papillomavirus type 4.p27(Kip1), elevated through increased protein synthesis is sequestered by cyclin D1-CDK4 complexes.J Biol Chem. 2001;276: 33861-33868
82. Ogawa T,Tomita Y,Okada M, et al. Broad-spectrum detection of papillomaviruses in bovine teat papillomas and healthy teat skin.J Gen Virol. 2004;85: 2191-2197
83. Olson C,Cook RH. Cutaneous sarcoma-like lesions of the horse caused by the agent of bovine papilloma.Proc Soc Exp Biol Med. 1951;77: 281-284
84. Olson C,Olson RO,Hubbard-Van Stelle S. Variations of response of cattle to experimentally induced viral papillomatosis.J Am Vet Med Assoc. 1992;201: 56-62
85. Olson C,Pamukcu AM,Brobst DF. Papilloma-like virus from bovine urinary bladder tumors.Cancer Res. 1965;25: 840-849
86. Olson C,Pamukcu AM,Brobst DF, et al. A urinary bladder tumor induced by a bovine cutaneous papilloma agent.Cancer Res. 1959;19: 779-782
87. Orbell GM,Young S,Munday JS. Cutaneous sarcoids in captive African lions associated with feline sarcoid-associated papillomavirus infection.Vet Pathol. 2011;48: 1176-1179
88. Orth G. Genetics of epidermodysplasia verruciformis: insights into host defense against papillomaviruses.Semin Immunol. 2006;18: 362-374
89. Pamukcu AM,Olson C,Goksoy SK. Influence of a papilloma vaccine on chronic bovine enzootic hematuria.Cancer Res. 1967;27: 2197-2200
90. Pamukcu AM,Yalciner S,Hatcher JF, et al. Quercetin, a rat intestinal and bladder carcinogen present in bracken fern (Pteridium aquilinum).Cancer Res. 1980;40: 3468-3472
91. Parkin DM. The global health burden of infection-associated cancers in the year 2002.Int J Cancer. 2006;118: 3030-3044
92. Pennie WD,Campo MS. Synergism between bovine papillomavirus type 4 and the flavonoid quercetin in cell transformation in vitro.Virology. 1992;190: 861-865
93. Pennie WD,Grindlay GJ,Cairney M, et al. Analysis of the transforming functions of bovine papillomavirus type 4.Virology. 1993;193: 614-620
94. Pett MR,Alazawi WO,Roberts I, et al. Acquisition of high-level chromosomal instability is associated with integration of human papillomavirus type 16 in cervical keratinocytes.Cancer Res. 2004;64: 1359-1368
95. Petti L,Nilson LA,DiMaio D. Activation of the platelet-derived growth factor receptor by the bovine papillomavirus E5 transforming protein.EMBO J. 1991;10: 845-855
96. Plowright W. Malignant neoplasia of the oesophagus and rumen of cattle in Kenya.J Comp Pathol. 1955;65: 108-114
97. Ragland WL,Keown GH,Gorham JR. An epizootic of equine sarcoid.Nature. 1966;210: 1399
98. Rector A,Van Ranst M. Animal papillomaviruses.Virology. 2013;445: 213-223
99. Robl MG,Olson C. Oncogenic action of bovine papilloma virus in hamsters.Cancer Res. 1968;28: 1596-1604
100. Roperto S,Borzacchiello G,Esposito I, et al. Productive infection of bovine papillomavirus type 2 in the placenta of pregnant cows affected with urinary bladder tumors.PLoS One. 2012;7: e33569
101. Roperto S,Brun R,Paolini F, et al. Detection of bovine papillomavirus type 2 in the peripheral blood of cattle with urinary bladder tumours: possible biological role.J Gen Virol. 2008;89: 3027-3033
102. Roperto S,Comazzi S,Ciusani E, et al. PBMCs are additional sites of productive infection of bovine papillomavirus type 2.J Gen Virol. 2011;92: 1787-1794
103. Roperto S,Russo V,Ozkul A, et al. Productive infection of bovine papillomavirus type 2 in the urothelial cells of naturally occurring urinary bladder tumors in cattle and water buffaloes.PLoS One. 2013;8: e62227
104. Rous P,Beard JW. The progression of carcinoma of virus-induced rabbit papillomas (shope).J Exp Med. 1935;62: 523-548
105. Rutten VP,Klein WR,De Jong MA, et al. Search for bovine papilloma virus DNA in bovine ocular squamous cell carcinomas (BOSCC) and BOSCC-derived cell lines.Am J Vet Res. 1992;53: 1477-1481
106. Sarkola ME,Grenman SE,Rintala MA, et al. Human papillomavirus in the placenta and umbilical cord blood.Acta Obstet Gynecol Scand. 2008;87: 1181-1188
107. Scheffner M,Werness BA,Huibregtse JM, et al. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53.Cell. 1990;63: 1129-1136
108. Schiller JT,Day PM,Kines RC. Current understanding of the mechanism of HPV infection.Gynecol Oncol. 2010;118: S12-S17
109. Schmitt M,Fiedler V,Muller M. Prevalence of BPV genotypes in a German cowshed determined by a novel multiplex BPV genotyping assay.J Virol Methods. 2010;170: 67-72
110. Schulman FY,Krafft AE,Janczewski T. Feline cutaneous fibropapillomas: clinicopathologic findings and association with papillomavirus infection.Vet Pathol. 2001;38: 291-296
111. Silva MA,Altamura G,Corteggio A, et al. Expression of connexin 26 and bovine papillomavirus E5 in cutaneous fibropapillomas of cattle.Vet J. 2013;195: 337-343
112. Silverberg MJ,Thorsen P,Lindeberg H, et al. Condyloma in pregnancy is strongly predictive of juvenile-onset recurrent respiratory papillomatosis.Obstet Gynecol. 2003;101: 645-652
113. Smith KT,Campo MS. “Hit and run” transformation of mouse C127 cells by bovine papillomavirus type 4: the viral DNA is required for the initiation but not for maintenance of the transformed phenotype.Virology. 1988;164: 39-47
114. Sterling JC,Handfield-Jones S,Hudson PM. Guidelines for the management of cutaneous warts.Br J Dermatol. 2001;144: 4-11
115. Stocco dos Santos RC,Lindsey CJ,Ferraz OP, et al. Bovine papillomavirus transmission and chromosomal aberrations: an experimental model.J Gen Virol. 1998;79: 2127-2135
116. Suprynowicz FA,Baege A,Sunitha I, et al. c-Src activation by the E5 oncoprotein enables transformation independently of PDGF receptor activation.Oncogene. 2002;21: 1695-1706
117. Suprynowicz FA,Disbrow GL,Simic V, et al. Are transforming properties of the bovine papillomavirus E5 protein shared by E5 from high-risk human papillomavirus type 16?.Virology. 2005;332: 102-113
118. Suprynowicz FA,Sparkowski J,Baege A, et al. E5 oncoprotein mutants activate phosphoinositide 3-kinase independently of platelet-derived growth factor receptor activation.J Biol Chem. 2000;275: 5111-5119
119. Teifke JP,Kidney BA,Lohr CV, et al. Detection of papillomavirus-DNA in mesenchymal tumour cells and not in the hyperplastic epithelium of feline sarcoids.Vet Dermatol. 2003;14: 47-56
120. Tolstov Y,Hadaschik B,Pahernik S, et al. Human papillomaviruses in urological malignancies: a critical assessment.Urol Oncol. 2014;32: 46.e19-27
121. Tong X,Howley PM. The bovine papillomavirus E6 oncoprotein interacts with paxillin and disrupts the actin cytoskeleton.Proc Natl Acad Sci U S A. 1997;94: 4412-4417
122. Tsirimonaki E,Ullah R,Marchetti B, et al. Similarities and differences between the E5 oncoproteins of bovine papillomaviruses type 1 and type 4: cytoskeleton, motility and invasiveness in E5-transformed bovine and mouse cells.Virus Res. 2006;115: 158-168
123. Underbrink MP,Howie HL,Bedard KM, et al. E6 proteins from multiple human betapapillomavirus types degrade Bak and protect keratinocytes from apoptosis after UVB irradiation.J Virol. 2008;82: 10408-10417
124. Vandepapeliere P,Barrasso R,Meijer CJ, et al. Randomized controlled trial of an adjuvanted human papillomavirus (HPV) type 6 L2 E7 vaccine: infection of external anogenital warts with multiple HPV types and failure of therapeutic vaccination.J Infect Dis. 2005;192: 2099-2107
125. Venuti A,Paolini F,Nasir L, et al. Papillomavirus E5: the smallest oncoprotein with many functions.Mol Cancer. 2011;10: 140
126. Wobeser BK,Hill JE,Jackson ML, et al. Localization of bovine papillomavirus in equine sarcoids and inflammatory skin conditions of horses using laser microdissection and two forms of DNA amplification.J Vet Diag Invest. 2012;24: 32-41
127. Yuan ZQ,Gault EA,Gobeil P, et al. Establishment and characterization of equine fibroblast cell lines transformed in vivo and in vitro by BPV-1: model systems for equine sarcoids.Virology. 2008;373: 352-361
128. Zimmermann H,Koh CH,Degenkolbe R, et al. Interaction with CBP/p300 enables the bovine papillomavirus type 1 E6 oncoprotein to downregulate CBP/p300-mediated transactivation by p53.J Gen Virol. 2000;81: 2617-2623
129. zur Hausen H,de Villiers EM,Gissmann L. Papillomavirus infections and human genital cancer.Gynecol Oncol. 1981;12: S124-S128